CDLX(CDLX)
CDLX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $153M | $164M |
| Low | $151M | $156M |
| High | $157M | $174M |
| EBITDA Avg | $-76M | $-81M |
| Low | $-78M | $-86M |
| High | $-75M | $-77M |
| EBIT Avg | $-89M | $-96M |
| Low | $-92M | $-102M |
| High | $-88M | $-91M |
| Net Income Avg | $-43M | $-41M |
| Low | $-46M | $-41M |
| High | $-42M | $-37M |
| EPS Avg | $-8.20 | $-7.35 |
| Low | $-8.68 | $-7.78 |
| High | $-7.85 | $-7.04 |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $39M | $41M | $35M | $39M | $43M | $48M |
| Low | $38M | $41M | $34M | $38M | $43M | $48M |
| High | $39M | $42M | $35M | $39M | $44M | $48M |
| EBITDA Avg | $-19M | $-21M | $-17M | $-19M | $-22M | $-24M |
| Low | $-19M | $-21M | $-17M | $-19M | $-22M | $-24M |
| High | $-19M | $-20M | $-17M | $-19M | $-21M | $-24M |
| EBIT Avg | $-23M | $-24M | $-20M | $-23M | $-25M | $-28M |
| Low | $-23M | $-25M | $-20M | $-23M | $-26M | $-28M |
| High | $-22M | $-24M | $-20M | $-22M | $-25M | $-28M |
| Net Income Avg | $-12M | $-10M | $-14M | $-12M | $-9M | $-6M |
| Low | $-16M | $-10M | $-14M | $-12M | $-9M | $-6M |
| High | $-7M | $-10M | $-14M | $-11M | $-9M | $-6M |
| EPS Avg | $-2.10 | $-1.83 | $-2.55 | $-2.10 | $-1.60 | $-1.10 |
| Low | $-2.86 | $-1.86 | $-2.58 | $-2.13 | $-1.62 | $-1.12 |
| High | $-1.34 | $-1.81 | $-2.52 | $-2.08 | $-1.58 | $-1.09 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |